Global Blood Lancets Market By Type (Vacuum Blood Lancets, Safety Blood Lancets and Standard Blood Lancets) By End Users (Homecare, Hospitals and Clinics, Blood Banks and other End Users) By Region, Industry Analysis and Forecast, 2019 - 2025
Special Offering: Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
Get in-depth analysis of the COVID-19 impact on the Blood Lancets Market
Market Report Description
The Global Blood Lancets Market size is expected to reach $1.5 billion by 2025, rising at a market growth of 8.5% CAGR during the forecast period. A blood lancet is described as a scalpel-like medical device which has a double-edged blade. The blade is used to pierce the skin to collect blood samples that are further used to diagnose multiple diseases such as hyperlipidemia of diabetes and dyslipidemia. Diabetic patients use these lancets regularly to track their blood glucose levels. A blood lancet is a portable medical device used for the collection of capillary blood. Furthermore, blood lancets find their uses in-home healthcare as well as in hospitals or pathology laboratories to confirm the blood group of individuals.
Global Blood Lancets Market Size
The major factors driving the growth of the blood lancets market include a significantly increased prevalence of chronic diseases like diabetes, hyperlipidemia, and dyslipidemia and increased inclination toward home care diagnostics. Additionally, the rise in the use of disposable blood lancets for painless diagnosis of blood sugar levels, hemoglobin, lipid levels, and other important blood components accelerates the growth of the industry.
Disposable lancet eliminates the risk of blood transfusion and transmission of infections and thus contributes to the growth of the blood lancets industry. Nevertheless, low awareness in developed countries about homecare lancet is expected to hamper the market growth. On the contrary, the favorable regulatory scenario is having a positive effect on the growth of the blood lancets market, thereby generating lucrative opportunities in the near future.
Blood Lancets Market Share
Recently, emerging and re-emerging infectious diseases like coronavirus disease poses a significant threat to public health in countries across the globe. Infectious diseases are the number one cause of morbidity and mortality worldwide. Diagnostics is the first step to treating infectious diseases and eradicating them. There is an urgent need to identify appropriate diagnostic strategies for better treatment of each disease due to the ever-evolving pathogens and emerging new diseases. In addition, effective diagnostic techniques are essential for disease identification and better treatment, as well as population outbreak control.
Based on Type, the market is segmented into Vacuum Blood Lancets, Safety Blood Lancets and Standard Blood Lancets. Based on End Users, the market is segmented into Homecare, Hospitals and Clinics, Blood Banks and other End Users. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.
Free Valuable Insights: Global Blood Lancets Market to reach a market size of $1.5 billion by 2025
The market research report covers theanalysis of key stake holders of the market. Key companies profiled in the report include Becton, Dickinson and Company, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Haemonetics Corporation, Nipro Corporation, Sarstedt AG & Company, F.L. Medical S.r.l., Socorex Isba SA, and PL Medical Co., LLC
Scope of the Blood Lancets Market Analysis
Market Segmentation:
By Type
- Vacuum Blood Lancets
- Safety Blood Lancets and
- Standard Blood Lancets
By End Users
- Homecare
- Hospitals and Clinics
- Blood Banks and
- other End Users
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Becton, Dickinson and Company
- Medtronic PLC
- Abbott Laboratories
- Terumo Corporation
- Haemonetics Corporation
- Nipro Corporation
- Sarstedt AG & Company
- L. Medical S.r.l.
- Socorex Isba SA
- PL Medical Co., LLC
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Blood Lancets Market Related Reports:
Q1. What would be the value of global blood lancets market in 2025?
The blood lancets market is projected to reach USD 1.5 billion by 2025.
Q2. What is the impact of COVID-19 pandemic on the driving and restraining factors of the blood lancets market?
The market is expected to witness a boost due to rise in the incidence of chronic diseases such as diabetes, high cholesterol, High prevalence of infectious diseases, and a rise in the usage of safety lancets. The market growth is expected to get affected due to coronavirus is disrupting the blood supply chain.
Q3. Which segment dominat market share in blood lancets market in 2018?
The standard llood lancets market dominated the global blood lancets Market by type in 2018.
Q4. Who are the top market players in the blood lancets industry?
Some of the key industry players are Becton, Dickinson and Company, Medtronic PLC, Abbott Laboratories, Terumo Corporation, Haemonetics Corporation, Nipro Corporation, Sarstedt AG & Company, F.L. Medical S.r.l., Socorex Isba SA, and PL Medical Co., LLC.